Yüklüyor......
Could the properties of IL-27 make it an ideal adjuvant for anticancer immunotherapy?
We have recently been the first to demonstrate that interleukin (IL)-27 protects against the emergence and progression of autochthonous tumors. Accumulating evidence suggests that IL-27 might be uniquely well positioned to amplify beneficial T(H)1 anticancer immune responses while suppressing the un...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Landes Bioscience
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3782520/ https://ncbi.nlm.nih.gov/pubmed/24083081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.25409 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|